Mortalin-enriched cancer cells have been shown to possess activated EMT, metastatic, angiogenic, cancer cell stemness, and drug resistance signaling, including activation of the Wnt/β-catenin pathway [15,52,53,54,55]. Here, HSPA9 is linked to cancer.